Three Finite Vascular Responses that Cause Coronary Heart Disease and Cardiovascular Disease: Implications for Diagnosis and Treatment

Yusuf S , Hawken S , Ounpuu S , et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. INTERHEART Study Investigators. Lancet, 2004; 364:937–952.

Houston MC . What Your Doctor May Not Tell You About Heart Disease. The Revolutionary Book that Reveals the Truth Behind Coronary Illnesses and How You Can Fight Them. New York: Grand Central Life and Style, Hachette Book Group, 2012.

3. O' Donnell CJ , Nabel EG . Genomics of cardiovascular disease. N Engl J Med, 2011; 365:2098–2109.

Houston MC . Nutrition and nutraceutical supplements in the treatment of hypertension. Expert Rev Cardiovasc Ther, 2010; 8:821–833.

ACCORD Study Group , Gerstein HC , Miller ME , et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med, 2011; 364:818–828.

Youssef-Elabd EM , McGee KC , Tripathi G . Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro. J Nutr Biochem, 2012; 23:39–50.

El Khatib N , Gé nieys S , Kazmierczak B , Volpert V . Mathematical modelling of atherosclerosis as an inflammatory disease. Philos Transact A Math Phys Eng Sci, 2009; 367:4877–4886.

Ko MJ , Jo AJ , Park CM , et al. Level of blood pressure control and cardiovascular events: SPRINT criteria versus the 2014 hypertension recommendations. J Am Coll Cardiol, 2016; 67:2821–2831.

Coutinho M , Gerstein HC , Wang Y , Yusuf S . The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care, 1999; 22:233–240.

Balkau B , Shipley M , Jarrett RJ , et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care, 1998; 21:360–367.

Pereg D , Elis A , Neuman Y , et al. Cardiovascular risk in patients with fasting blood glucose levels within normal range. Am J Cardiol, 2010; 106:1602–1605.

Carey RM , Whelton PK . Prevention, detection, evaluation, and management of high blood pressure in adults: Synopsis of the 2017 American College of Cardiology/American Heart Association hypertension guideline. 2017 ACC/AHA Hypertension Guideline Writing Committee. Ann Intern Med, 2018; 168:351–358.

Houston MC , Basile J , Bestermann WH , et al. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci, 2005; 329:276–291.

Bestermann W , Houston MC , Basile J , et al. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: Treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Am J Med Sci, 2005; 329:292–305.

Duprez DA , Florea N , Zhong W , et al. Vascular and cardiac functional and structural screening to identify risk of future morbid events: Preliminary observations. J Am Soc Hypertens, 2011; 5:401–409.

Houston MC . Handbook of Hypertension. Oxford, United Kingdom: Wiley, Blackwell, 2009.

17. O' Brien E , White WB , Parati G , Dolan E . Ambulatory blood pressure monitoring in the 21st century. J Clin Hypertens, 2018; 20:1108–1111.

Houston M . The role of nutraceutical supplements in the treatment of dyslipidemia. J Clin Hypertens, 2012; 14:121–132.

Siti HN , Kamisah Y , Kamsiah J . The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascul Pharmacol, 2015; 71:40–56.

20. Razzouk, Munter P , Bansilal S , et al. C reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. Am Heart J, 2009; 158:277–283.

Martinez BK , White CM . The emerging role of inflammation in cardiovascular disease. Ann Pharmacother, 2018; 52:801–809.

Epelman S , Liu PP , Mann DL . Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol, 2015; 15:117–129.

Wen Y , Crowley SD . Renal effects of cytokines in hypertension. Curr Opin Nephrol Hypertens, 2018; 27:70–76.

Van Laecke S , Malfait T , Schepers E , Van Biesen W . Cardiovascular disease after transplantation: An emerging role of the immune system. Transpl Int, 2018; 31:689–699.

Petrie JR , Guzik TJ , Touyz RM . Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms. Can J Cardiol, 2018; 34:575–584.

Caillon A , Mian MO , Fraulob-Aquino JC , et al. Gamma delta t cells mediate angiotensin II-induced hypertension and vascular injury. Circulation, 2017; 135:2155–2162.

Solanki A , Bhatt LK , Johnston TP . Evolving targets for the treatment of atherosclerosis. Pharmacol Ther, 2018; 187:1–12.

De Ciuceis C , Agabiti-Rosei C , Rossini C , et al. Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans. Blood Press, 2017; 26:237–245.

Justin Rucker A , Crowley SD . The role of macrophages in hypertension and its complications. Pflugers Arch, 2017; 469:419–430.

Ritchie RH , Drummond GR , Sobey CG , et al. The opposing roles of NO and oxidative stress in cardiovascular disease. Pharmacol Res, 2017; 116:57–69.

Lundberg AM , Yan ZQ . Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation. Curr Opin Lipidol, 2011; 22:343–349.

Zhao L , Lee JY , Hwang DH . Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals. Nutr Rev, 2011; 69:310–320.

Mah E , Bruno RS . Postprandial hyperglycemia on vascular endothelial function: Mechanisms and consequences. Nutr Res, 2012; 32:727–740.

Fazio S , Linton MF . High-density lipoprotein therapeutics and cardiovascular prevention. J Clin Lipidol, 2010; 4:411–419.

van der Steeg WA , Holme I , Boekholdt SM , et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk: The IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol, 2008; 51:634–642.

Matsuzawa Y , Sugiyama S , Sugamura K , et al. Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol, 2010; 55:1688–1696.

Bonetti PO , Pumper GM , Higano ST , et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol, 2004; 44:2137–2141.

Hamburg NM , Keyes MJ , Larson MG , et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation, 2008; 117:2467–2674.

Schoenenberger AW , Urbanek N , Bergner M , et al. Associations of reactive hyperemia index and intravascular ultrasound-assessed coronary plaque morphology in patients with coronary artery disease. Am J Cardiol, 2012; 109:1711–1716.

Matsuzawa Y , Sugiyama S , Sumida H , et al. Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc, 2013; 2:e000426.

Prisant LM , Pasi M , Jupin D , Prisant ME . Assessment of repeatability and correlates of arterial compliance. Blood Press Monit, 2002; 7:231–235.

Cohn JN , Hoke L , Whitwam W , et al. Screening for early detection of cardiovascular disease in asymptomatic individuals. Am Heart J, 2003; 146:679–685.

Nelson MR , Stepanek J , Cevette M , et al. Noninvasive measurement of central vascular pressures with arterial tonometry: Clinical revival of the pulse pressure waveform?. Mayo Clin Proc, 2010; 85:460–472.

Hashimoto J , Ito S . Some mechanical aspects of arterial aging: Physiological overview based on pulse wave analysis. Ther Adv Cardiovasc Dis, 2009; 3:367–378.

Johnsen SH , Mathiesen EB . Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep, 2009; 11:21–27.

Bots ML , Taylor AJ , Kastelein JJ , et al. Rate of change in carotid intima-media thickness and vascular events: Meta-analyses cannot solve all the issues. A point of view. J Hypertens, 2012; 30:1690–1696.

Lorenz MW , Markus HS , Bots ML , et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation, 2007; 115:459–467.

Rizzoni D , Porteri E , Duse S , et al. Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry. J Hypertens, 2012; 30:1169–1675.

Ying GS , Maguire M , Pistilli M , et al. Chronic Renal Insufficiency Cohort (CRIC) study group association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] study). Am J Cardiol, 2012; 110:246–253.

Virdis A , Savoia C , Grassi G , et al. Evaluation of microvascular structure in humans: A “state-of-the-art” document of the working group on macrovascular and microvascular alterations of the Italian Society of Arterial Hypertension. J Hypertens, 2014; 32:2120–2129.

Al-Fiadh AH , Wong TY , Kawasaki R , et al. Usefulness of retinal microvascular endothelial dysfunction as a predictor of coronary artery disease. Am J Cardiol, 2015; 115:609–613.

Folsom AR , Kronmal RA , Detrano RC , et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med, 2008; 168:1333–1339.

Choi Y , Chang Y , Ryu S , et al. Relation of dietary glycemic index and glycemic load to coronary artery calcium in asymptomatic Korean adults. Am J Cardiol, 2015; 116:520–526.

Ahmadi N , Tsimikas S , Hajsadeghi F , et al. Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium. Am J Cardiol, 2010; 105:459–466.

Raggi P , Callister TQ , Shaw LJ . Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol, 2004; 24:1272–1277.

Criqui MH , Denenberg JO , Ix JH , et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA, 2014; 311:271–278.

Schmermund A , Elsä sser A , Behl M , et al. Comparison of prognostic usefulness (three years) of computed tomographic angiography versus 64-slice computed tomographic calcium scanner in subjects without significant coronary artery disease. Am J Cardiol, 2010; 106:1574–1579.

Ochs MM , Siepen FA , Fritz T , et al. Limits of the possible: Diagnostic image quality in coronary angiography with third-generation dual-source CT. Clin Res Cardiol, 2017; 106:485–492.

Rong J , Bai SR , Chen YL , He C . Increased detection of coronary atherosclerosis on 320-slice computed tomographic angiography with burden of cardiovascular risk factors and complications in patients with type 2 diabetes. J Diabetes Complications, 2016; 30:494–500.

Kawaji T , Kimura T . The diagnostic performance of Multifunction Cardiogram (MCG) in functional myocardial ischemia. Ann Noninvasive Electrocardiol, 2015; 20:508–510.

Kawaji T , Shiomi H , Morimoto T , et al. Noninvasive detection of functional myocardial ischemia: Multifunction Cardiogram Evaluation in Diagnosis of Functional Coronary Ischemia Study (MED-FIT). Ann Noninvasive Electrocardiol, 2015; 20:44–6.

Kandori A , Ogata K , Miyashita T , et al. Subtraction magnetocardiogram for detecting coronary heart disease. Ann Noninvasive Electrocardiol, 2010; 15:360–368.

Kwon H , Kim K , Lee YH , et al. Non-invasive magnetocardiography for the early diagnosis of coronary artery disease in patients presenting with acute chest pain. Circ J, 2010; 74:1424–1430.

Greenwood JP , Herzog BA , Brown JM , et al. Prognostic value of cardiovascular magnetic resonance and single-photon emission computed tomography in suspected coronary heart disease: Long-term follow-up of a prospective, diagnostic accuracy cohort study. Ann Intern Med, 2016; 165:1–9.

Emami H , Tawakol A . Noninvasive imaging of arterial inflammation using FDG-PET/CT. Curr Opin Lipidol, 2014; 25:431–437.

Houston MC . The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis, 2010; 4:165–183.

Sofi F , Abbate R , Gensini GF , Casini A . Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis. Am J Clin Nutr, 2010; 92:1189–1896.

Estruch R , Ros E , Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med, 2013; 368:1279–1290.

Nadtochiy SM , Redman EK . Mediterranean diet and cardioprotection: The role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition, 2011; 27:733–744.

de Lorgeril M , Salen P , Martin JL , et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation, 1999; 99:779–785.

Buckland G , Mayén AL, Agudo A , et al. Olive oil intake and mortality within the Spanish population (EPIC-Spain). Am J Clin Nutr, 2012; 96:142–149.

72. Castañ er O , Corella D , Covas MI , et al. In vivo transcriptomic profile after a Mediterranean diet in high-cardiovascular risk patients: A randomized controlled trial. Am J Clin Nutr, 2013; 98:845–853.

Konstantinidou V , Covas MI , Sola R , Fitó M. Up-to date knowledge on the in vivo transcriptomic effect of the Mediterranean diet in humans. Mol Nutr Food Res, 2013; 57:772–783.

Corella D , Ordovás JM. How does the Mediterranean diet promote cardiovascular health? Current progress toward molecular mechanisms: Gene–diet interactions at the genomic, transcriptomic, and epigenomic levels provide novel insights into new mechanisms. Bioessays, 2014; 36:526–537.

75. Salas-Salvadó J, Bulló M, Estruch R , et al. Prevention of diabetes with Mediterranean diets: A subgroup analysis of a randomized trial. Ann Intern Med, 2014; 160:1–10.

Appel LJ , Moore TJ , Obarzanek E , et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med, 1997; 336:1117–1124.

Sacks FM , Svetkey LP , Vollmer WM , et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH–Sodium Collaborative Research Group. N Engl J Med, 2001; 344:3–10.

Fung TT , Chiuve SE , McCullough ML , et al. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med, 2008; 168:713–720.

Jenkins DJ , Kendall CW , Marchie A , et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr, 2005; 81:380–387.

Jenkins DJ , Jones PJ , Lamarche B , et al. Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: A randomized controlled trial. JAMA, 2011; 306:831–839.